Original Literature | Model OverView |
---|---|
Publication
Title
Mechanisms for the anti-inflammatory effects of adiponectin in macrophages.
Affiliation
Department of Pathobiology, Cleveland Clinic, Cleveland, OH 44195, USA.
Abstract
Adiponectin is an adipokine with potent anti-inflammatory properties. Thedevelopment of alcoholic liver disease is thought to involve increasedpro-inflammatory activity, mediated in part by the activation of hepaticmacrophages (Kupffer cells). Chronic ethanol feeding sensitizes hepaticmacrophages to activation by lipopolysaccharide (LPS), leading to increasedproduction of reactive oxygen species and tumor necrosis factor-alpha(TNF-alpha). Adiponectin can normalize Toll-like receptor-4 (TLR-4) mediatedsignaling in hepatic macrophages after ethanol feeding, likely contributing tothe hepatoprotective effect of adiponectin in the progression of alcoholic liverdisease. However, the mechanisms by which adiponectin suppress TLR-4 mediatedresponses are not well understood. Using the macrophage-like cell line,RAW264.7, we have investigated the molecular mechanisms by which adiponectinsuppresses LPS-stimulated TNF-alpha production. Globular adiponectin(gAcrp)-mediated desensitization of LPS-stimulated responses in RAW264.7macrophages was dependent on the production of the anti-inflammatory cytokineinterleukin (IL)-10. gAcrp initially increased TNF-alpha expression in RAW264.7macrophages; this TNF-alpha then contributed to increased expression of IL-10.This initial gAcrp-mediated increase in TNF-alpha production by macrophages wasmediated via activation of ERK1/2-->Egr-1 and nuclear factor(NF)-kappaB-dependent mechanisms. gAcrp-stimulated IL-10 expression was alsodependent on the phosphorylation of cAMP response element-binding protein andthe cAMP response element in the IL-10 promoter. In summary, these studiesreveal a complex, integrated response of macrophages to gAcrp. gAcrp initiallyactivated signaling pathways considered to be pro-inflammatory, with asubsequent increase in the expression of the potent, anti-inflammatory cytokine,IL-10. Increased IL-10 expression was ultimately required for the suppression ofTLR4-mediated signaling by gAcrp.
PMID
18336664
|
Entity
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12
10
infinite
0
TRANSPATH | MO000000058 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
adiponectin
--
MO000022523
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6806
10
infinite
0
InterPro | IPR008161 |
TRANSPATH | MO000022523 |
--
fatty acids
--
MO000033598
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m12273
10
infinite
0
TRANSPATH | MO000033598 |
--
ERK{p}
--
MO000038306
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16522
10
infinite
0
TRANSPATH | MO000038306 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
fatty acids{oxidated}
--
e11
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m11
10
infinite
0
TRANSPATH | MO000033598 |
--
NF-kappaB{activated}
--
e12
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m13
10
infinite
0
TRANSPATH | MO000000058 |
--
csml-variable:Double
m15
0
infinite
0
--
ethanol
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m16
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
csml-variable:Double
m23
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
ROS
--
e5
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
cytokines
--
e6
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c4 : 1
stoichiometry:c45 : 1
stoichiometry:c3 : 1
m155666*m5*m16*0.1
nodelay
--
0
PMID: 18336664 Endotoxin/lipopolysaccharide (LPS), a component of the cell wall of Gram-negative bacteria, is an important activator of Kupffer cells, stimulating the production of inflammatory and fibrogeniccytokines, as well as reactive oxygen species (ROS). PMID: 18336664, 9756487 One working model for the progression of alcoholic liver disease proposes that increased exposure of Kupffer cells to LPS during chronic ethanol consumption contributes to increased production of inflammatory mediators, in particular tumor necrosis factor TNF-alpha and ROS, leading to the progression of fatty liver, inflammation and fibrosis.
p10
p10
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c31 : 1
m230*0.1
nodelay
--
0
PMID: 18336664 IL-10 expression is induced by various inflammatory mediators, such as LPS and TNF-alpha. PMID: 18336664, 17537727 Interestingly, we found that initially adiponectin increases the production of TNF-alpha by RAW 264.7 macrophages; this TNF-alpha, in the continued presence of adiponectin, then increases production of IL-10.
p11
p11
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c40 : 1
stoichiometry:c33 : 1
m94230*m6806*0.1
nodelay
--
0
PMID: 18336664, 1940369, 1940799, 8386517 IL-10 then acts to limit excessive production of pro-inflammatory cytokines, including TNF-alpha and IL-1b by decreasing cytokine gene transcription, as well as regulating the stability and/or translation of target mRNAs. PMID: 18336664, 17537727 Treatment of RAW 264.7 macrophages with adiponectin increases the expression of IL-10 mRNA and peptide. PMID: 18336664, 17537727 Interestingly, we found that initially adiponectin increases the production of TNF-alpha by RAW 264.7 macrophages; this TNF-alpha, in the continued presence of adiponectin, then increases production of IL-10.
p12
p12
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c35 : 1
m93364*0.1
nodelay
--
0
PMID: 18336664, 1940369, 1940799, 8386517 IL-10 then acts to limit excessive production of pro-inflammatory cytokines, including TNF-alpha and IL-1b by decreasing cytokine gene transcription, as well as regulating the stability and/or translation of target mRNAs.
p13
p13
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c38 : 1
m6806*0.1
nodelay
--
0
PMID: 18336664, 15369797, 17537727 While the mechanisms for the long-term anti-inflammatory effects of adiponectin are not well understood, recent data suggest that adiponectin acts, at least in part, to increase the expression of anti-inflammatory mediators, such as interleukin (IL)-10. PMID: 18336664, 17537727 Treatment of RAW 264.7 macrophages with adiponectin increases the expression of IL-10 mRNA and peptide.
p14
p14
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c42 : 1
m93309*m6806*0.1
nodelay
--
0
PMID: 18336664, 17537727 Interestingly, we found that initially adiponectin increases the production of TNF-alpha by RAW 264.7 macrophages; this TNF-alpha, in the continued presence of adiponectin, then increases production of IL-10. PMID: 18336664 This initial gAcrp-mediated increase in TNF-alpha production by macrophages was mediated via activation of ERK1/2¢ªEgr-1 and nuclear factor (NF)-kappaB-dependent mechanisms.
p15
p15
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m6806*m14*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter.
p16
p16
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m6806*m17*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter.
p17
p17
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c57 : 1
m2057*m16522*m18*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m19*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c65 : 1
stoichiometry:c64 : 1
m21*m23*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter.
p2
p2
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c5 : 1
stoichiometry:c15 : 1
stoichiometry:c6 : 1
m155666*m6*0.1
nodelay
--
0
PMID: 18336664 Endotoxin/lipopolysaccharide (LPS), a component of the cell wall of Gram-negative bacteria, is an important activator of Kupffer cells, stimulating the production of inflammatory and fibrogeniccytokines, as well as reactive oxygen species (ROS). PMID: 18336664, 16410364, 10961870, 15033490 Adiponectin suppresses phagocytic activity, as well as lipopolysaccharide (LPS)- stimulated cytokine production in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c62 : 1
m22*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter. PMID: 18336664 gAcrp-stimulated IL-10 expression was also dependent on the phosphorylation of cAMP response element-binding protein and the cAMP response element in the IL-10 promoter.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c69 : 1
stoichiometry:c68 : 1
m12*m6806*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter (Park, et al., unpubl. obs, 2007); and (ii) an NF-kappaB and Egr-1 pathway, leading to increased production of TNF-alpha.
p22
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c72 : 1
stoichiometry:c71 : 1
m2058*m16522*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter (Park, et al., unpubl. obs, 2007); and (ii) an NF-kappaB and Egr-1 pathway, leading to increased production of TNF-alpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c73 : 1
m24*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter (Park, et al., unpubl. obs, 2007); and (ii) an NF-kappaB and Egr-1 pathway, leading to increased production of TNF-alpha. PMID: 18336664 This initial gAcrp-mediated increase in TNF-alpha production by macrophages was mediated via activation of ERK1/2¢ªEgr-1 and nuclear factor (NF)-kappaB-dependent mechanisms.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c74 : 1
m13*0.1
nodelay
--
0
PMID: 18336664 We next identified two parallel signaling pathways required for adiponectin-stimulated IL-10 transcription: (i) an ERK1/2- and protein kinase A (PKA)-dependent increase in cAMP response element-binding protein (CREB) phosphorylation which acted via the CRE in the IL-10 promoter (Park, et al., unpubl. obs, 2007); and (ii) an NF-kappaB and Egr-1 pathway, leading to increased production of TNF-alpha. PMID: 18336664 This initial gAcrp-mediated increase in TNF-alpha production by macrophages was mediated via activation of ERK1/2¢ªEgr-1 and nuclear factor (NF)-kappaB-dependent mechanisms.
p3
p3
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c9 : 1
stoichiometry:c34 : 1
stoichiometry:c46 : 1
stoichiometry:c8 : 1
m155666*m93309*m16*0.1
nodelay
--
0
PMID: 18336664, 9756487 One working model for the progression of alcoholic liver disease proposes that increased exposure of Kupffer cells to LPS during chronic ethanol consumption contributes to increased production of inflammatory mediators, in particular tumor necrosis factor TNF-alpha and ROS, leading to the progression of fatty liver, inflammation and fibrosis. PMID: 18336664, 1940369, 1940799, 8386517 IL-10 then acts to limit excessive production of pro-inflammatory cytokines, including TNF-alpha and IL-1b by decreasing cytokine gene transcription, as well as regulating the stability and/or translation of target mRNAs. PMID: 18336664 Increased IL-10 expression was ultimately required for the suppression of TLR4-mediated signaling by gAcrp.
p4
p4
cso30:i:ME_Oxidation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c12 : 1
stoichiometry:c11 : 1
m12273*m6806*0.1
nodelay
--
0
PMID: 18336664, 12840063 Importantly, treatment of mice with adiponectin during chronic ethanol exposure prevents the development of ethanol-induced liver injury,26 in part by increasing fatty acid oxidation in the liver, thus preventing ethanol-induced steatosis, as well as decreasing TNF-alpha expression.
p5
p5
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c41 : 1
stoichiometry:c13 : 1
m16*0.1
nodelay
--
0
PMID: 18336664, 12840063 Importantly, treatment of mice with adiponectin during chronic ethanol exposure prevents the development of ethanol-induced liver injury,26 in part by increasing fatty acid oxidation in the liver, thus preventing ethanol-induced steatosis, as well as decreasing TNF-alpha expression. PMID: 18336664, 16410364 Importantly, overnight treatment of Kupffer cells with adiponectin can normalize the chronic ethanol-induced sensitization of LPS-stimulated TNF-alpha expression, normalizing the increased production of ROS, as well as ERK1/2 and p38 phosphorylation.
p6
p6
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c18 : 1
stoichiometry:c23 : 1
stoichiometry:c49 : 1
stoichiometry:c17 : 1
m12*m155666*m16*0.1
nodelay
--
0
PMID: 18336664, 16410364, 15033490, 16325814 In particular, LPS-stimulated NK-kappaB and ERK1/2 activation are sensitive to the inhibitory effects of adiponectin.
p7
p7
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c22 : 1
stoichiometry:c47 : 1
stoichiometry:c21 : 1
stoichiometry:c20 : 1
m14*m16*m155666*0.1
nodelay
--
0
PMID: 18336664, 16410364, 15033490, 16325814 In particular, LPS-stimulated NK-kappaB and ERK1/2 activation are sensitive to the inhibitory effects of adiponectin. PMID: 18336664, 16410364 Importantly, overnight treatment of Kupffer cells with adiponectin can normalize the chronic ethanol-induced sensitization of LPS-stimulated TNF-alpha expression, normalizing the increased production of ROS, as well as ERK1/2 and p38 phosphorylation.
p8
p8
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c48 : 1
stoichiometry:c24 : 1
m155666*m20*m16*0.1
nodelay
--
0
PMID: 18336664, 16410364 Importantly, overnight treatment of Kupffer cells with adiponectin can normalize the chronic ethanol-induced sensitization of LPS-stimulated TNF-alpha expression, normalizing the increased production of ROS, as well as ERK1/2 and p38 phosphorylation.
p9
p9
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c30 : 1
m155666*0.1
nodelay
--
0
PMID: 18336664 IL-10 expression is induced by various inflammatory mediators, such as LPS and TNF-alpha.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--